Actinic Keratosis Olsen Grade I/II
1 clinical trials · Condition
◉ Watch Actinic Keratosis Olsen Grade I/II
| Record | Firm | Date |
|---|---|---|
| Study Whose Purpose is to Find an Optimal Dose for the Treatment With AK 3012 in Patients With Actinic Keratosis (NCT01757613) | Dolorgiet GmbH & Co. KG | 2012-12-01 |
Track Actinic Keratosis Olsen Grade I/II automatically
Every clearance here is in the API, with alerts when new ones post.